Source link : https://newshealth.biz/health-news/got-patients-with-refractory-axspa-or-psa-consider-this-option/
(MedPage Today) — Although most patients with axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA) didn’t respond adequately to the interleukin-17 (IL-17) inhibitor ixekizumab (Taltz), enough did that it should still be considered in such… Source link : https://www.medpagetoday.com/rheumatology/arthritis/116666 Author : Publish date : 2025-07-25 12:48:00 Copyright for syndicated content belongs to the linked Source.
The post Got Patients With Refractory axSpA or PsA? Consider This Option first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-25 12:48:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8